Modulation of Short-Chain Fatty Acids as Potential Therapy Method for Type 2 Diabetes Mellitus
In recent years, the relationship between intestinal microbiota (IM) and the pathogenesis of type 2 diabetes mellitus (T2DM) has attracted much attention. The beneficial effects of IM on the metabolic phenotype of the host are often considered to be mediated by short-chain fatty acids (SCFAs), mainl...
Saved in:
| Main Authors: | Ruiqi Tang, Lanjuan Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
| Online Access: | http://dx.doi.org/10.1155/2021/6632266 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Maternal treatment with short-chain fatty acids modulates the intestinal microbiota and immunity and ameliorates type 1 diabetes in the offspring.
by: James C Needell, et al.
Published: (2017-01-01) -
Therapeutic potential of gut microbiota modulation in epilepsy: A focus on short-chain fatty acids
by: Rong Yan, et al.
Published: (2025-06-01) -
Gracilaria extract reduce hyperglycemia by modulating gut microbial and short chain fatty acids
by: Zhiqun Li, et al.
Published: (2024-12-01) -
Role of short-chain fatty acids in non-alcoholic fatty liver disease and potential therapeutic targets
by: Xiang Qin, et al.
Published: (2025-04-01) -
The Effects of Short-Chain Fatty Acids in Urological Diseases
by: Hee Jo Yang, et al.
Published: (2022-04-01)